Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Post

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
What Patients with Bipolar Disorder Need to Know about LithiumRobert M Post, Janusz K Rybakowski
CNS Neuroscience & Therapeutics|December 17, 2010
Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disordersRobert M Post, Susan R B Weiss
Development and Psychopathology|September 28, 2002
Psychological complexity: barriers to its integration into the neurobiology of major psychiatric disordersRobert M Post, Susan R B Weiss
Clinical EEG and Neuroscience|April 29, 2004
Convergences in course of illness and treatments of the epilepsies and recurrent affective disordersRobert M Post, Susan R B Weiss
Epilepsy Research|August 2, 2002
Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disordersFernando Lopes da Silva, Robert M Post
The Primary Care Companion for CNS Disorders|September 17, 2020
Little Agreement on Treating Residual Bipolar Disorder Symptoms in a ChildRobert M Post, Michael Rowe, Robert Findling
Psychiatry Research|December 16, 2016
Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation studySibel Cakir, Olcay Yazıcı, Robert M Post
Journal of Psychiatric Research|March 27, 2012
Neurobiological correlates of illness progression in the recurrent affective disordersRobert M Post, Jaclyn Fleming, Flavio Kapczinski
Journal of Clinical Psychopharmacology|January 19, 2002
New designs for studies of the prophylaxis of bipolar disorderRobert M Post, Paul Keck, A John Rush
The Journal of Clinical Psychiatry|December 4, 2014
Controversies in the psychopharmacology of bipolar disorderRobert M Post, Michael J Ostacher, Vivek Singh
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
What Patients with Bipolar Disorder Need to Know about LithiumRobert M Post, Janusz K Rybakowski
CNS Neuroscience & Therapeutics|December 17, 2010
Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disordersRobert M Post, Susan R B Weiss
Development and Psychopathology|September 28, 2002
Psychological complexity: barriers to its integration into the neurobiology of major psychiatric disordersRobert M Post, Susan R B Weiss
Clinical EEG and Neuroscience|April 29, 2004
Convergences in course of illness and treatments of the epilepsies and recurrent affective disordersRobert M Post, Susan R B Weiss
Epilepsy Research|August 2, 2002
Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disordersFernando Lopes da Silva, Robert M Post
The Primary Care Companion for CNS Disorders|September 17, 2020
Little Agreement on Treating Residual Bipolar Disorder Symptoms in a ChildRobert M Post, Michael Rowe, Robert Findling
Psychiatry Research|December 16, 2016
Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation studySibel Cakir, Olcay Yazıcı, Robert M Post
Journal of Psychiatric Research|March 27, 2012
Neurobiological correlates of illness progression in the recurrent affective disordersRobert M Post, Jaclyn Fleming, Flavio Kapczinski
Journal of Clinical Psychopharmacology|January 19, 2002
New designs for studies of the prophylaxis of bipolar disorderRobert M Post, Paul Keck, A John Rush
The Journal of Clinical Psychiatry|December 4, 2014
Controversies in the psychopharmacology of bipolar disorderRobert M Post, Michael J Ostacher, Vivek Singh
Pageof 20